CorMedix Inc. to Participate in the RBC Global Healthcare Conference
CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company specializing in therapeutic products for life-threatening diseases, has announced its participation in the upcoming RBC Capital Markets Global Healthcare Conference. The event will be held in New York from May 20-21, 2025. The company will engage in a fireside chat format presentation scheduled for Wednesday, May 21, 2025, at 3:05 p.m. EDT. A webcast link will be available for interested parties to follow the presentation.
CorMedix Inc. (NASDAQ: CRMD), un'azienda biofarmaceutica specializzata in prodotti terapeutici per malattie gravi, ha annunciato la sua partecipazione alla RBC Capital Markets Global Healthcare Conference. L'evento si terrà a New York dal 20 al 21 maggio 2025. La società prenderà parte a una presentazione in formato fireside chat, programmata per mercoledì 21 maggio 2025 alle 15:05 EDT. Sarà disponibile un link webcast per chiunque voglia seguire la presentazione.
CorMedix Inc. (NASDAQ: CRMD), una empresa biofarmacéutica especializada en productos terapéuticos para enfermedades graves, ha anunciado su participación en la próxima RBC Capital Markets Global Healthcare Conference. El evento se llevará a cabo en Nueva York del 20 al 21 de mayo de 2025. La compañía participará en una presentación en formato charla informal programada para el miércoles 21 de mayo de 2025 a las 3:05 p.m. EDT. Habrá un enlace web disponible para quienes deseen seguir la presentación.
CorMedix Inc. (NASDAQ: CRMD)는 생명을 위협하는 질병 치료제를 전문으로 하는 생명공학 제약회사로, 다가오는 RBC Capital Markets Global Healthcare Conference에 참가한다고 발표했습니다. 행사는 2025년 5월 20일부터 21일까지 뉴욕에서 열립니다. 회사는 2025년 5월 21일 수요일 오후 3시 5분(동부 표준시)에 파이어사이드 채팅 형식의 발표를 진행할 예정입니다. 발표를 시청할 수 있는 웹캐스트 링크가 제공될 예정입니다.
CorMedix Inc. (NASDAQ : CRMD), une société biopharmaceutique spécialisée dans les produits thérapeutiques pour les maladies graves, a annoncé sa participation à la prochaine RBC Capital Markets Global Healthcare Conference. L'événement se tiendra à New York du 20 au 21 mai 2025. L'entreprise participera à une présentation au format discussion informelle le mercredi 21 mai 2025 à 15h05 EDT. Un lien de webdiffusion sera disponible pour les personnes intéressées souhaitant suivre la présentation.
CorMedix Inc. (NASDAQ: CRMD), ein biopharmazeutisches Unternehmen, das sich auf therapeutische Produkte für lebensbedrohliche Krankheiten spezialisiert hat, hat seine Teilnahme an der bevorstehenden RBC Capital Markets Global Healthcare Conference angekündigt. Die Veranstaltung findet vom 20. bis 21. Mai 2025 in New York statt. Das Unternehmen wird an einer Fireside-Chat-Präsentation am Mittwoch, den 21. Mai 2025, um 15:05 Uhr EDT teilnehmen. Ein Webcast-Link wird für Interessierte zur Verfügung gestellt, um die Präsentation zu verfolgen.
- None.
- None.
BERKELEY HEIGHTS, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the RBC Capital Markets Global Healthcare Conference, taking place in New York on May 20-21, 2025.
| RBC Capital Markets Global Healthcare Conference | |
| Date: | Wednesday, May 21, 2025 |
| Time: | 3:05p.m. EDT |
| Format: | Fireside Chat |
| Webcast: | Link |
About CorMedix
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath® (taurolidine and heparin) which was approved by the FDA on November 15, 2023. CorMedix commercially launched DefenCath in inpatient settings in April 2024 and in outpatient settings in July 2024. CorMedix is commencing clinical studies in adult Total Parenteral Nutrition (TPN) patients and pediatric hemodialysis (HD) patient populations in 2025 and also intends to develop DefenCath as a catheter lock solution for use in other therapeutic areas. For more information visit: www.cormedix.com.
Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576
FAQ
When is CorMedix (CRMD) presenting at the RBC Global Healthcare Conference 2025?
What type of company is CorMedix (CRMD)?
Where is the RBC Global Healthcare Conference 2025 being held?
How can I watch the CorMedix (CRMD) presentation at the RBC Healthcare Conference?
